Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
K1 Competence Center - Initiated by the Federal Ministry of Transport, Innovation and Technology (BMVIT)
and the Federal Ministry of Science, Research and Economy (BMWFW).
Funded by the Austrian Research Promotion Agency (FFG), Land Steiermark and the Styrian Business
Promotion Agency (SFG).
Hier “rcpe ppt header Large 01.emf” platzieren
Optical Coherence Tomography (OCT) for Real-time Evaluation of Pharmaceutical Films and CoatingsManufactured & Distributed by
Overview of Analyzed Pharmaceuticals
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 2
Enteric & modified release tablets
Further tabletsCo-extrusion
Hard- and soft-gel capsules
MultiparticulatesThe world of
OCT in Pharma
OCT is based on (coherence gated) interferometry
Broad bandwidth resulting low-coherence length
Defines the axial (=depth) resolution – 5µm
Light is split in reference and probe path
Optics of sample arm focus light and define
lateral (=surface) resolution – 14µm in focus
Interference of light reflected back from both paths
Spectrometer (grating, CCD line scan camera)
Depth-information is generated from interference
fringes by Fourier-transformation (FFT)
Depth scan measurement rate: 100kHz
Slide 3Source: http://obel.ee.uwa.edu.au/research/fundamentals/introduction-oct/
slightly modified by adding OCT tablet image
Interferometry: The Technology behind OCT
May 2018 Patrick Wahl - OCT for Pharmaceutical Films and Coatings
Schematic of a Fourier domain OCT system
Slide 4
Each interferogram one depth reading (“A-scan”, 1D)
A-scan rate: 100kHz max.
Multiple A-scans cross-sectional image (“B-scan”, 2D)
Demands moving of objects or scanning sensor beam
Multiple B-scans full OCT volume (“C-scan”, 3D)
Raster-scanning of probe with sensor beam
The “ABC of OCT” - Nomenclature
May 2018 Patrick Wahl - OCT for Pharmaceutical Films and Coatings
OSeeT pharma 1D is based on B-scans,
by moving objects relative to the OCT sensor
(e.g. tablets in a pan coater)Implementation
in a pan coater
Coating Quality Characteristics of Enteric and Controlled Release Tablet Coatings
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 5
Coating layer is of biopharmaceutical importance
Thickness
Impact on dissolution time, diffusion kinetics
Thickness variability (between and within tablet)
Might directly impact variability in dissolution rate
RSD after coating is still significant (see later)
Roughness
Surface affects water uptake
Correlation to optical appearance
Homogeneity
The structure within the coating
Agglomerate of excipients, air bubbles, …
Might link to dissolution variability
coating
tablet core
air
thickness
thickness variability
/ roughness
homogeneity
Better understanding of coating quality
brings significant benefit in
formulation and process development
Advantages of OCT
May 2018 Slide 6 Patrick Wahl - OCT for Pharmaceutical Films and Coatings
Why OCT? for in-line measurement of coatings
Direct measurement of coating thickness & quality
No chemometric modelling low Total Cost of Ownership
No indirect monitoring of growth via D50 shift of particle size
Statistically relevant; hundreds of samples evaluated per minute
Wealth of information
Mean coating thickness over whole run
Coating variability between particles
Homogeneity and roughness of coating
Ease of use; intuitive software requiring no special scientific training
Coating thickness
OCT
Weight gain
Diameter gain
PSD
NIR / Raman
THz
Applications
In-line Monitoring of a Pan Coating Process
Process development: fast coating quality and thickness analysis during DoE studies
Scale-up: compare coating quality and thickness between different scales
Manufacturing: end-point detection independent of spray efficiency or process variations
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 9
Air purging of
probe window
Mounting close to suction shoe
At-line Sampling Device for In-Process Control
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 10
Miniaturized drum-set up tailored to
mimic large scale pan coater
Fast analysis of representative number
of tablets at-line in manufacturing area
Confirm coating end-point,
independent of process variations
Feasibility Study
Differentiating Coating Quality with OCT
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 11
Good coating process
Lower scattering in coating indicating a uniform
coating layer
Coating-Core interface clearly visible
Sub-optimal process
Highly scattering coating layer likely caused by
incomplete film forming or poorly dispersed talc
Less ballistic photons reach coating-core interface,
resulting in poorer contrast
EUDRAGIT® L30 D-55 does not show curing
Thus, process conditions for coating must be well chosen
Coating quality differences can be determined with OCT
Monitoring of a Fluid Bed Coating Process
Emulation of a Wurster coater fluid bed process
Up to 250rpm = ~2m/s circumferential speed
Pellets: Cellets 1000, 40µm coating
Probe can measure through glass of fluid bed coater
From 1 mm to 25 mm thickness
Tests in industrial Wurster coaters lab and production
scale (MiniGlatt and Glatt GPCG30 with 18” tube)
have been performed
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 12
Pellets with a velocity of ~2m/s
(typical for Wurster coaters)
Fluid Bed OCT Probe
Pellets on rotating disc
Glass window
(hidden)
Example image of
Wurster coater
Suggested
OCT probe
location
Co-extrusion of Core-Skin Reservoir System
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsSlide 13May 2018
Real (“the ugly”) co-extruded strand
Rough core and/or skin
Variations in skin thickness
Desired (“the good”) co-extruded strand
Spherical core and skin
Identical center point
Resulting in homogenous skin thickness
Co-extrusion product:
NuvaRing for birth control
sourc
e:
ourm
om
ento
ftru
th.c
om
Use Case 1: End-point Detection
In-line Monitoring of a Pan Coating Process
Coating: PVA, 50µm end-point control
Core: 10mm biconvex tablets, 50kg batch
Pan coater: Glatt GCC 150
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 17
Run 1a-d: Identical process parameters (replicates)
Run 2: Higher spray gun to bed distance:
Lead to spray drying
Same weight gain, also for lower efficiency
Run 3: Larger cores:
Less total surface area lower total amount sprayed (kg)
Higher area per tablet higher weight gain (mg)
Reliable end-point detection via OCT
Use Case 2: Process Development of Semi-continuous Coating
Example Use Case: Semi-continuous Coating
Lab-scale continuous pan
coater
DRIACONTI – T, Driam GmbH
Coating
EUDRAGIT® L30 D-55
Triethyl citrate
Talc
Reference Measurements
(off-line)
3D-OCT
Precision caliper
Weight gain
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 19
1 2 3
OCT
Three coating chambers
Charge
of cores
Discharge
of coated
tablets
Results
Comparison of Measurement Techniques for Coating Thickness
All methods were performed on same tablet samples (n=10), except batch weight gain
Lowest SD for OCT measurement – compared to diameter gain and weight gain
OCT and diameter gain show consistent results
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 20
OCT Diameter gain Weight gain
Results
Analysis of Semi-Continuous Coating Runs
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 21
Variation in mean coating thickness for conti-runs higher
Conti runs 3+4
Inter-tablet variability more than doubled
Lower mean coating thickness
Coating mass is partially contradictory
Equal results of batch/tablet for replicate runs
Contradictory for conti-runs
Hypothesis / Conclusion
Nozzle clogging for chosen process parameters
Exchange of some tablets between segments Overfilling of the drum? Tablets being stuck?
Further analysis for confirmation needed!
OCT
Wrap-Up
Wrap-Up – OCT for Pharmaceutical Films and Coatings
Coating characterization
OCT is a calibration free method
no chemometric modelling needed - only refractive index
Mean coating thickness over whole run
Inter- and intra-particle coating variability
Homogeneity and roughness of coating
OCT brings the quality and confidence
of labor intensive and manual methods (e.g. diameter gain)
to a real-time in-line method with additional insights in coating quality
Patrick Wahl - OCT for Pharmaceutical Films and CoatingsMay 2018 Slide 23
K1 Competence Center - Initiated by the Federal Ministry of Transport, Innovation and Technology (BMVIT)
and the Federal Ministry of Science, Research and Economy (BMWFW).
Funded by the Austrian Research Promotion Agency (FFG), Land Steiermark and the Styrian Business
Promotion Agency (SFG).
Hier “rcpe ppt header Large 01.emf” platzieren
Thank you for your attention!Questions?
OSeeT Pharma 1D
Manufactured & Distributed by
www.phyllon.at